Bengaluru: Liquor baron Vijay Mallya has submitted before the Karnataka High Court that the Rs 6,200 crore debt he owes to banks has been recovered "multiple times over," and sought a statement of ...

A self-proclaimed reviewer, who's known for sharing his two cents on big-banner films, has claimed that Vidaamuyarchi is better than all of Ajith's rival Vijay's recent movies. In his typical ...

He made his first start of the season last week at the AT&T Pebble Beach Pro-Am, also on a sponsor exemption (one of his primary sponsors is AT&T) and finished T69 out of 78 players. The PGA Tour ...

Due to surgery on his left wrist, Spieth (+7000) was making his first start since mid-August and placed T69. After a third-round 79 in the most challenging conditions of the week, he rebounded ...

Golf and Grateful Dead? 10 songs that resemble PGA Tour, LIV golfers Two different worlds have come together. Here are 10 Grateful Dead songs corresponding to some of the world’s best golfers ...

One start, one win for Rory McIlroy on the PGA Tour in 2025. The 35-year-old picked up his 27th career PGA Tour victory Sunday, claiming the 2025 AT&T Pebble Beach Pro-Am. He finished at 21 under ...

Addressing the party's workers and leaders, Vijay asserted that the work to strengthen the party is underway. "Now, works on strengthening the party is going on. Our first goal is the 2026 Elections.

Political strategist Aadhav Arjuna, the son-in-law of 'Lottery King' Santiago Martin, on Saturday officially joined Thalapathy Vijay's political outfit Thamizhaga Vetri Kazhagam (TVK). Arjuna was ...

Two months after sharing dais with actor-politician Vijay and criticising the ruling DMK as a party of dynasts, former VCK leader Aadhav Arjuna on Friday joined Vijay’s Tamilaga Vetri Kazhagam (TVK).

Rory McIlroy won for the 27th time on the PGA Tour. / Kyle Terada-Imagn Images The PGA Tour’s second signature event of 2025 was at Pebble Beach (and Spyglass Hill) this week, where a field of ...

The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to treat moderate-to-severe acute ...